Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05266937
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-01
First Post:
2020-02-10
Brief Title:
Atezolizumab Plus CArboplatin Plus Nab-paclitaxel
Sponsor:
Consorzio Oncotech
Organization:
Consorzio Oncotech
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-03
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-10
First Submit QC Date:
February 23 2022
Study First Post Date:
2022-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-31
Last Update Post Date:
2024-02-01
Last Update Post Date Type:
ACTUAL